CME/CE
The Evolving Role of Biomarkers in IgAN
4:45
Faculty: Chee Kay Cheung, MBChB, MRCP, PhD
This comprehensive educational activity focuses on 4 key dimensions of IgA nephropathy (IgAN) management. First, attendees will compare and contrast the mechanisms of action (MOAs) of both approved and investigational IgAN therapies, critically evaluating how each targets specific disease pathways—such as galactose-deficient IgA1 formation, complement…